Osteoclasts secrete IL-19 ligands to act on the IL-20RB of tumor cells, thus activating the JAK1/STAT3 signaling pathway to promote proliferation of disseminated tumor cells and colonization in bone. Here, JAK1 is linked to neoplasm.